COVID-19 is not an extinction event for optometry, but that does not diminish its stressful and humbling effects. The post-COVID-19 landscape is bound to change many facets of eye care, including consumer behavior, business strategy and practice operation. What follows is a view into each of these windows of what may lie ahead.
A new era has arrived for CsA, with the powerful combination of a higher concentration offered in conjunction with advanced drug delivery technology. This important clinical development is giving eye care practitioners another tool to help manage the chronic and inflammatory nature of DED for their patients.
You’ve taken the kids for their checkups and scheduled your parents’ doctor visits. You even went along to make sure they understand what was happening.
Nikki Iravani, OD, is always on the lookout for a great marketing tip.
Nine women ODs were honored during the fourth annual Theia Awards of Excellence from Women In Optometry magazine.